Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 223

1.

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.

Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, Roth T.

Sleep. 2011 Oct 1;34(10):1433-42. doi: 10.5665/SLEEP.1294.

PMID:
21966075
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.

Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T.

Sleep. 2010 Nov;33(11):1553-61.

PMID:
21102997
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia.

Lankford A, Rogowski R, Essink B, Ludington E, Heith Durrence H, Roth T.

Sleep Med. 2012 Feb;13(2):133-8. doi: 10.1016/j.sleep.2011.09.006. Epub 2011 Dec 24.

PMID:
22197474
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.

Scharf M, Rogowski R, Hull S, Cohn M, Mayleben D, Feldman N, Ereshefsky L, Lankford A, Roth T.

J Clin Psychiatry. 2008 Oct;69(10):1557-64. Epub 2008 Oct 7.

PMID:
19192438
[PubMed - indexed for MEDLINE]
5.

Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.

Roth T, Rogowski R, Hull S, Schwartz H, Koshorek G, Corser B, Seiden D, Lankford A.

Sleep. 2007 Nov;30(11):1555-61.

PMID:
18041488
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.

Roth T, Soubrane C, Titeux L, Walsh JK; Zoladult Study Group.

Sleep Med. 2006 Aug;7(5):397-406. Epub 2006 Jul 3.

PMID:
16815744
[PubMed - indexed for MEDLINE]
7.

Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.

Zammit G, Erman M, Wang-Weigand S, Sainati S, Zhang J, Roth T.

J Clin Sleep Med. 2007 Aug 15;3(5):495-504. Erratum in: J Clin Sleep Med. 2008 Oct 15;4(5):table of contents. J Clin Sleep Med. 2007 Oct 15;3(6):table of contents.

PMID:
17803013
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.

Hajak G, Rodenbeck A, Voderholzer U, Riemann D, Cohrs S, Hohagen F, Berger M, Rüther E.

J Clin Psychiatry. 2001 Jun;62(6):453-63.

PMID:
11465523
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.

Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M.

Sleep. 2009 Mar;32(3):351-60.

PMID:
19294955
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.

Sleep Med. 2006 Jun;7(4):312-8. Epub 2006 May 18.

PMID:
16709464
[PubMed - indexed for MEDLINE]
11.

A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.

Ancoli-Israel S, Krystal AD, McCall WV, Schaefer K, Wilson A, Claus R, Rubens R, Roth T.

Sleep. 2010 Feb;33(2):225-34.

PMID:
20175406
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Efficacy and safety of doxepin 6 mg in a model of transient insomnia.

Roth T, Heith Durrence H, Jochelson P, Peterson G, Ludington E, Rogowski R, Scharf M, Lankford A.

Sleep Med. 2010 Oct;11(9):843-7. doi: 10.1016/j.sleep.2010.07.006.

PMID:
20817598
[PubMed - indexed for MEDLINE]
13.

Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.

Roth T, Hull SG, Lankford DA, Rosenberg R, Scharf MB; Intermezzo Study Group.

Sleep. 2008 Sep;31(9):1277-84.

PMID:
18788653
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomnia.

Rosenberg R, Seiden DJ, Hull SG, Erman M, Schwartz H, Anderson C, Prosser W, Shanahan W, Sanchez M, Chuang E, Roth T.

Sleep. 2008 Dec;31(12):1663-71.

PMID:
19090322
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.

Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T.

Sleep. 2003 Nov 1;26(7):793-9.

PMID:
14655910
[PubMed - indexed for MEDLINE]
16.

Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.

Elie R, Rüther E, Farr I, Emilien G, Salinas E.

J Clin Psychiatry. 1999 Aug;60(8):536-44.

PMID:
10485636
[PubMed - indexed for MEDLINE]
17.

A polysomnography study of eszopiclone in elderly patients with insomnia.

McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T.

Curr Med Res Opin. 2006 Sep;22(9):1633-42.

PMID:
16968566
[PubMed - indexed for MEDLINE]
18.

A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.

Erman MK, Zammit G, Rubens R, Schaefer K, Wessel T, Amato D, Caron J, Walsh JK.

J Clin Sleep Med. 2008 Jun 15;4(3):229-34.

PMID:
18595435
[PubMed - indexed for MEDLINE]
Free PMC Article
19.
20.

Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.

Walsh JK, Soubrane C, Roth T.

Am J Geriatr Psychiatry. 2008 Jan;16(1):44-57. doi: 10.1097/JGP.0b013e3181256b01.

PMID:
18165461
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk